Medical Diagnostic Control Set Supply

The contract calls for the supply of stabilized whole blood matrix control sets specifically designed for use with Sysmex hematology analyzers, providing low, normal, and high-level tri-pack configurations with four 2.0 mL vials per level, enabling comprehensive quality control across a broad range of testing parameters. These control sets are engineered to monitor up to 22 blood chemistry parameters, ensuring accurate and consistent performance validation across multiple analyzer runs and laboratory environments. The product must maintain stability and performance consistency to meet the stringent requirements of clinical diagnostic laboratories. This subcontract is issued under the NAICS code 325414 for medical and diagnostic laboratory supplies, with the Department of Defense’s Medical Supply Chain MD Surg FSF as the contracting entity. The solicitation was posted on April 29, 2026, and responses are due by May 5, 2026, creating a narrow window for qualification and submission. While no specific place of performance or point of contact is detailed, the procurement is intended to support DOD medical operations, requiring suppliers to demonstrate capacity, compliance with quality standards, and reliability in delivery to ensure uninterrupted diagnostic service across military and allied healthcare facilities.